Supersapiens Reader Version Zero News Today : Breaking News, Live Updates & Top Stories | Vimarsana

, a Bluetooth-compatible, real-time data app, developed what it hopes is the latest breakthrough in sports continuous glucose monitoring (CGM). In fact, the sports tech company this week announced it had secured $13.5 million in venture capital funding to develop product. Could CGM biosensors be the next trend in fitness wearables? We already measure our caloric intake, heart rate, rate of oxygen consumption, calories burned before, during, and after exercise — so why not glucose, too? A cyclist wearing the Abbott CGM biosensor “Using the Abbott Libre Sense Biosensor and the compatible ...

Share this article Share this article ATLANTA, April 27, 2021 /PRNewswire/ -- Supersapiens announces a $13.5 million capital raise led by MICA Ventures AG. The new energy management ecosystem, powered by Abbott's Libre Sense Glucose Sport Biosensor, has secured the largest investment in the sports continuous glucose monitoring (CGM) space, garnering investment from preeminent fitness and performance brands including the founder of Zwift and Wahoo. Supersapiens Closes $13.5 Million in Early-Stage Funding Joining lead investor Michael Hartweg, founder of MICA Ventures AG, is Ed Baker, former V...